References

Treatment of oral erosive Lichen planus with upadacitinib

10.1001/jamadermatol.2022.0147 · ExternalCitation · doi-reference

Oral acitretin plus topical triamcinolone vs topical triamcinolone monotherapy in patients with symptomatic oral lichen planus: a randomized clinical trial

10.1001/jamadermatol.2023.4889 · ExternalCitation · doi-reference

Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019

10.1001/jamaoncol.2021.6987 · ExternalCitation · doi-reference

Nivolumab for patients with high-risk oral leukoplakia: a nonrandomized controlled trial

10.1001/jamaoncol.2023.4853 · ExternalCitation · doi-reference

Oncological outcomes of patients with oral potentially malignant disorders

10.1001/jamaoto.2024.3719 · ExternalCitation · doi-reference

A high prevalence of p53 mutations in pre-malignant oral erythroplakia

10.1002/(sici)1097-0215(19990129)80:3<345::aid-ijc2>3.0.co;2-n · ExternalCitation · doi-reference

Erythroplakia of the oral cavity

10.1002/1097-0142(197509)36:3<1021::aid-cncr2820360327>3.0.co;2-w · ExternalCitation · doi-reference

Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity

10.1002/1097-0142(20011101)92:9<2349::aid-cncr1582>3.0.co;2-i · ExternalCitation · doi-reference

Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults

10.1002/14651858.cd010173.pub3 · ExternalCitation · doi-reference

Jiawei danxuan koukang and its component kaempferol alleviate oral submucous fibrosis by restoring epithelial-fibroblast homeostasis and suppressing neutrophil recruitment via the ANXA1/FPR2 axis

10.1002/fsn3.71785 · ExternalCitation · doi-reference

Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype

10.1002/hed.26006 · ExternalCitation · doi-reference

Clinical management update of oral leukoplakia: a review from the American head and neck society cancer prevention service

10.1002/hed.28013 · ExternalCitation · doi-reference

Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias

10.1002/ijc.24611 · ExternalCitation · doi-reference

Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia

10.1002/ijc.27720 · ExternalCitation · doi-reference

PA28γ induces dendritic cell maturation and activates T-cell immune responses in oral lichen planus

10.1002/mco2.561 · ExternalCitation · doi-reference

Topical imiquimod for oral cavity leukoplakia and dysplasia: a scoping review

10.1002/ohn.70107 · ExternalCitation · doi-reference

Integrative analysis of genomic and transcriptomic data of normal, tumour, and co-occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour initiation and progression

10.1002/path.5900 · ExternalCitation · doi-reference

Function of unconventional T cells in oral lichen planus revealed by single-cell RNA sequencing

10.1007/s00011-024-01912-6 · ExternalCitation · doi-reference

Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development

10.1007/s00784-020-03575-z · ExternalCitation · doi-reference

The association of candida and antifungal therapy with pro-inflammatory cytokines in oral leukoplakia

10.1007/s00784-021-03927-3 · ExternalCitation · doi-reference

Proliferative verrucous leukoplakia is associated with aggressive periodontal pathogens: a comparative study with oral lichen planus and chronic periodontitis cases

10.1007/s00784-025-06525-9 · ExternalCitation · doi-reference

Bacterial extracellular vesicles as potential promoting factors for oral Lichen planus pathogenesis

10.1007/s10753-024-02146-8 · ExternalCitation · doi-reference

Aberrant accumulation of cell-free DNA activates the cGAS-STING-TBK1 pathway of γδ T cells to promote the inflammatory responses in oral Lichen planus

10.1007/s10753-025-02416-z · ExternalCitation · doi-reference

Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis

10.1007/s11427-021-1965-x · ExternalCitation · doi-reference

A retrospective 20-Year analysis of proliferative verrucous leukoplakia and its progression to malignancy and association with high-risk human papillomavirus

10.1007/s12105-018-0893-7 · ExternalCitation · doi-reference

Proliferative verrucous leukoplakia: an expert consensus guideline for standardized assessment and reporting

10.1007/s12105-020-01262-9 · ExternalCitation · doi-reference

Immunohistochemical coexpression of MUC1 and MUC4 in oral leukoplakia and oral squamous cell carcinoma

10.1007/s12105-021-01291-y · ExternalCitation · doi-reference

Qualitative assessment of collagen and elastic fibers in oral submucous fibrosis (OSMF), OSMF with dysplasia and oral squamous cell carcinoma arising from OSMF: a histochemical study

10.1007/s12105-023-01591-5 · ExternalCitation · doi-reference

Etiopathogenesis of oral lichen planus: a review

10.1007/s12105-025-01807-w · ExternalCitation · doi-reference

Exploring topical atorvastatin hyalurosomal gel as an adjuvant for reducing systemic corticosteroid dosage: a randomized clinical trial in severe oral lichen planus patients

10.1007/s13346-025-01956-z · ExternalCitation · doi-reference

Oral lichen planus: an update on diagnosis and management

10.1007/s40257-023-00814-3 · ExternalCitation · doi-reference

Proliferative verrucous leukoplakia and erythroplakia are probably the disorders with the highest rate of malignant transformation

10.1016/j.adaj.2020.01.035 · ExternalCitation · doi-reference

Oral and non-oral lichen planus show genetic heterogeneity and differential risk for autoimmune disease and oral cancer

10.1016/j.ajhg.2024.04.020 · ExternalCitation · doi-reference

Oral submucous fibrosis: regulatory mechanism of collagen metabolism and management

10.1016/j.biopha.2026.119053 · ExternalCitation · doi-reference

Fumarate loss destabilizes mitochondria and activates cGAS-STING in OLP

10.1016/j.biopha.2026.119127 · ExternalCitation · doi-reference

Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals

10.1016/j.canlet.2016.03.042 · ExternalCitation · doi-reference

Targeting the genetic landscape of oral potentially malignant disorders has the potential as a preventative strategy in oral cancer

10.1016/j.canlet.2021.05.025 · ExternalCitation · doi-reference

Integrated multi-omics analyses of oral squamous cell carcinoma reveal precision patient stratification and personalized treatment strategies

10.1016/j.canlet.2025.217482 · ExternalCitation · doi-reference

Oxidative stress, inflammation, and cancer: how are they linked?

10.1016/j.freeradbiomed.2010.09.006 · ExternalCitation · doi-reference

Expression of FAP in oral leukoplakia and oral squamous cell carcinoma

10.1016/j.identj.2023.12.011 · ExternalCitation · doi-reference

Heat shock protein 70-2 is overexpressed in oral leukoplakia and oral squamous cell carcinoma

10.1016/j.identj.2024.10.008 · ExternalCitation · doi-reference

SOX11 and GLIS2: novel biomarkers for understanding the progression of oral leukoplakia

10.1016/j.identj.2025.100872 · ExternalCitation · doi-reference

Meis1 negatively regulates epithelial-mesenchymal transition via Wnt/β-catenin pathway in oral submucous fibrosis

10.1016/j.identj.2025.109323 · ExternalCitation · doi-reference

Aberrantly downregulated FENDRR by arecoline elevates ROS and myofibroblast activation via mitigating the miR-214/MFN2 axis

10.1016/j.ijbiomac.2024.130504 · ExternalCitation · doi-reference

Different expression profiles of circulating miR-31 and miR-181a in CD4+ T cells and plasma of patients with oral lichen planus

10.1016/j.intimp.2023.110306 · ExternalCitation · doi-reference

BMP5 mediates macrophage-driven oral leukoplakia carcinogenesis

10.1016/j.intimp.2026.116232 · ExternalCitation · doi-reference

Trace elements (copper, zinc, selenium and molybdenum) as markers in oral sub mucous fibrosis and oral squamous cell carcinoma

10.1016/j.jtemb.2013.04.003 · ExternalCitation · doi-reference

Identification of proteomic biomarkers in proliferative verrucous leukoplakia through liquid chromatography with tandem mass spectrometry

10.1016/j.labinv.2023.100222 · ExternalCitation · doi-reference

Adhesive lipophilic gels delivering rapamycin prevent oral leukoplakia from malignant transformation

10.1016/j.mtbio.2024.101305 · ExternalCitation · doi-reference

Adhesive hydrogel delivering ALA prevents the malignant transformation of oral leukoplakia

10.1016/j.mtbio.2026.103017 · ExternalCitation · doi-reference

Dysbiosis of the gut microbiome may contribute to the pathogenesis of oral Lichen planus through treg dysregulation

10.1016/j.mucimm.2025.05.009 · ExternalCitation · doi-reference

Advancing oral leukoplakia progression recognition: a benchmark with dataset, method, and application

10.1016/j.neunet.2025.108256 · ExternalCitation · doi-reference

FTO deficiency facilitates epithelia dysfunction in oral lichen planus

10.1016/j.omtn.2025.102463 · ExternalCitation · doi-reference

Acetaldehyde production and microbial colonization in oral squamous cell carcinoma and oral lichenoid disease

10.1016/j.oooo.2013.02.009 · ExternalCitation · doi-reference

MicroRNA-375 as a biomarker for malignant transformation in oral lesions

10.1016/j.oooo.2016.07.022 · ExternalCitation · doi-reference

Oral submucous fibrosis: review on aetiology and pathogenesis

10.1016/j.oraloncology.2005.08.005 · ExternalCitation · doi-reference

Molecular screening of oral precancer

10.1016/j.oraloncology.2013.09.005 · ExternalCitation · doi-reference

MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder

10.1016/j.oraloncology.2015.11.017 · ExternalCitation · doi-reference

Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers

10.1016/j.oraloncology.2017.07.015 · ExternalCitation · doi-reference

Podoplanin and ABCG2 expression in oral erythroplakia revisited: potential evidence for cancer stem cells driving the process of field cancerization

10.1016/j.oraloncology.2019.07.011 · ExternalCitation · doi-reference

Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis

10.1016/j.oraloncology.2019.07.012 · ExternalCitation · doi-reference

Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma

10.1016/j.oraloncology.2021.105191 · ExternalCitation · doi-reference

Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: a systematic review and meta-analysis

10.1016/j.oraloncology.2022.105734 · ExternalCitation · doi-reference

Salivary microRNA- 375: a novel biomarker in the malignant transformation of oral potentially malignant disorders

10.1016/j.oraloncology.2022.106065 · ExternalCitation · doi-reference

A simple clinicaapproach to diagnose oral erythroplakia, the potentially malignant disorder with the highest rate of malignant development into squamous cell carcinoma

10.1016/j.oraloncology.2022.106126 · ExternalCitation · doi-reference

Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms

10.1016/j.oraloncology.2024.106737 · ExternalCitation · doi-reference

The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders

10.1016/j.oraloncology.2025.107583 · ExternalCitation · doi-reference

The effects of photodynamic and low-level laser therapy for treatment of oral lichen planus-A systematic review and meta-analysis

10.1016/j.pdpdt.2018.07.001 · ExternalCitation · doi-reference

Deciphering the pharmacological mechanisms of Scutellaria baicalensis georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations

10.1016/j.phymed.2022.154195 · ExternalCitation · doi-reference

Cucurbitacin B induces ferroptosis in oral leukoplakia via the SLC7A11/mitochondrial oxidative stress pathway

10.1016/j.phymed.2024.155548 · ExternalCitation · doi-reference

Identification of high-risk oral leukoplakia (OLK) using combined raman spectroscopic analysis of brush biopsy and saliva samples: a proof of concept study

10.1016/j.saa.2025.125721 · ExternalCitation · doi-reference

The small GTP-Binding Ras-like protein DIRAS2 promotes cell proliferation in oral leukoplakia via the RAF/MEK/MAPK pathway

10.1016/j.tice.2025.103037 · ExternalCitation · doi-reference

FAP promotes progression of oral leukoplakia via activation of PI3K/AKT pathway by interacting with ITGB1

10.1016/j.tranon.2025.102531 · ExternalCitation · doi-reference

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

10.1016/s1470-2045(20)30737-3 · ExternalCitation · doi-reference

Multimodal serum profiling for early detection and risk assessment of oral potentially malignant disorders and oral cancer

10.1021/acs.analchem.5c06663 · ExternalCitation · doi-reference

Host-guest assembly of transmucosal molecular spherical nucleic acids for oral leukoplakia immunotherapy and microbiota homeostasis restoration

10.1021/jacsau.6c00012 · ExternalCitation · doi-reference

Upregulation of epidermal growth factor receptor 4 in oral leukoplakia

10.1038/ijos.2013.10 · ExternalCitation · doi-reference

Cigarette smoke promotes oral leukoplakia via regulating glutamine metabolism and M2 polarization of macrophage

10.1038/s41368-021-00128-2 · ExternalCitation · doi-reference

Oral squamous cell carcinomas: state of the field and emerging directions

10.1038/s41368-023-00249-w · ExternalCitation · doi-reference

Stromal thrombospondin 1 suppresses angiogenesis in oral submucous fibrosis

10.1038/s41368-024-00286-z · ExternalCitation · doi-reference

Oral submucous fibrosis: pathogenesis and therapeutic approaches

10.1038/s41368-024-00344-6 · ExternalCitation · doi-reference

Abnormal collagen deposition mediated by cartilage oligomeric matrix protein in the pathogenesis of oral submucous fibrosis

10.1038/s41368-025-00355-x · ExternalCitation · doi-reference

Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology

10.1038/s41416-021-01411-z · ExternalCitation · doi-reference

Migrasome-transported PTGES amplifies the PGE2 cascade in SPP1+ macrophages to drive oral leukoplakia carcinogenesis

10.1038/s41467-026-70824-2 · ExternalCitation · doi-reference

The evolutionary history of 2,658 cancers

10.1038/s41586-019-1907-7 · ExternalCitation · doi-reference

Oral Lichen planus and oral squamous cell carcinoma share key oncogenic signatures

10.1038/s41598-022-24801-6 · ExternalCitation · doi-reference

Novel transcripts of EMT driving the malignant transformation of oral submucous fibrosis

10.1038/s41598-025-87790-2 · ExternalCitation · doi-reference

Next-generation AI framework for comprehensive oral leukoplakia evaluation and management

10.1038/s41746-025-01885-8 · ExternalCitation · doi-reference

Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous oral submucous fibrosis

10.1038/srep34314 · ExternalCitation · doi-reference

Dysbiosis and interactions of the mycobiome and bacteriome in mucosal lesions of erosive and non-erosive oral Lichen planus patients

10.1080/20002297.2024.2374639 · ExternalCitation · doi-reference

Does a link exist between oral microbiota and oral squamous cell carcinoma? A review of current insights

10.1080/20002297.2025.2569934 · ExternalCitation · doi-reference

Efficacy of hydroxychloroquine in oral lichen planus: a retrospective review

10.1093/bjd/ljac113 · ExternalCitation · doi-reference

Spatial proteomics reveals layer-specific molecular landscapes and keratin 17-mediated inflammatory crosstalk in oral Lichen planus of the tongue

10.1093/bjd/ljag040 · ExternalCitation · doi-reference

Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study

10.1093/jnci/djz238 · ExternalCitation · doi-reference

Identification of genomic alteration and prognosis using pathomics-based artificial intelligence in oral leukoplakia and head and neck squamous cell carcinoma: a multicenter experimental study

10.1097/js9.0000000000002077 · ExternalCitation · doi-reference

Artificial intelligence for predicting post-excision recurrence and malignant progression in oral potentially malignant disorders: a retrospective cohort study

10.1097/js9.0000000000003592 · ExternalCitation · doi-reference

Apremilast in oral Lichen planus - a multicentric, retrospective study

10.1111/ddg.14696 · ExternalCitation · doi-reference

High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia

10.1111/imm.13565 · ExternalCitation · doi-reference

Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis

10.1111/j.1600-0714.2007.00625.x · ExternalCitation · doi-reference

Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: a review

10.1111/j.1600-0714.2008.00669.x · ExternalCitation · doi-reference

Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer

10.1111/j.1600-0714.2012.01191.x · ExternalCitation · doi-reference

Oral cancer and oral erythroplakia: an update and implication for clinicians

10.1111/j.1834-7819.2011.01337.x · ExternalCitation · doi-reference

Potential role of INTERLEUKIN-17 in the pathogenesis of oral lichen planus: a systematic review with META-analysis

10.1111/jdv.18219 · ExternalCitation · doi-reference

Outcome and long-term treatment protocol for topical tacrolimus in oral Lichen planus

10.1111/jdv.18457 · ExternalCitation · doi-reference

Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder

10.1111/jop.13304 · ExternalCitation · doi-reference

Significance of cytoplasmic cyclin D1 expression in oral oncogenesis

10.1111/odi.12752 · ExternalCitation · doi-reference

Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO collaborating centre for oral cancer

10.1111/odi.13704 · ExternalCitation · doi-reference

Oral cancer development in Lichen planus and related conditions-3.0 evidence level: a systematic review of systematic reviews

10.1111/odi.13812 · ExternalCitation · doi-reference

Oral epithelial dysplasia: Recognition, grading and clinical significance

10.1111/odi.13993 · ExternalCitation · doi-reference

Immune mechanisms in oral lichen planus

10.1111/odi.14142 · ExternalCitation · doi-reference

Manganese suppresses the development of oral leukoplakia by activating the immune response

10.1111/odi.14412 · ExternalCitation · doi-reference

Salivary biomarkers: effective diagnostic tool for oral leukoplakia and oral squamous cell carcinoma

10.1111/odi.14835 · ExternalCitation · doi-reference

Malignant transformation of oral leukoplakia: systematic review and comprehensive meta-analysis

10.1111/odi.15140 · ExternalCitation · doi-reference

Cancer hallmarks expression in oral leukoplakia: systematic review and meta-analysis

10.1111/odi.70106 · ExternalCitation · doi-reference

White, red, and mixed lesions of oral mucosa: a clinicopathologic approach to diagnosis

10.1111/prd.12276 · ExternalCitation · doi-reference

Recent advancements in artificial intelligence-powered cancer prediction from oral microbiome

10.1111/prd.70000 · ExternalCitation · doi-reference

Elucidating the genetic landscape of oral leukoplakia to predict malignant transformation

10.1158/1078-0432.ccr-22-2210 · ExternalCitation · doi-reference

YAP-induced endothelial-mesenchymal transition in oral submucous fibrosis

10.1177/0022034519851804 · ExternalCitation · doi-reference

Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990-2017

10.1177/0022034519894963 · ExternalCitation · doi-reference

Copy number alterations predict development of OSCC from oral leukoplakia

10.1177/00220345231217160 · ExternalCitation · doi-reference

Recurrence in oral leukoplakia: a systematic review and meta-analysis

10.1177/00220345241266519 · ExternalCitation · doi-reference

A deep learning system to predict epithelial dysplasia in oral leukoplakia

10.1177/00220345241272048 · ExternalCitation · doi-reference

Oral epithelial dysplasia grading systems: a systematic review and meta-analysis

10.1177/10668969211070171 · ExternalCitation · doi-reference

Deregulation of circ_003912 contributes to pathogenesis of erosive oral Lichen planus by via sponging microRNA-123, -647 and -31 and upregulating FOXP3

10.1186/s10020-021-00382-4 · ExternalCitation · doi-reference

Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral Lichen planus susceptibility

10.1186/s12903-016-0277-x · ExternalCitation · doi-reference

Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma

10.1186/s12903-023-02887-2 · ExternalCitation · doi-reference

Photodynamic therapy (PDT) for oral leukoplakia: a systematic review and meta-analysis of single-arm studies examining efficacy and subgroup analyses

10.1186/s12903-023-03294-3 · ExternalCitation · doi-reference

Oral erythroplakia and oral erythroplakia-like oral squamous cell carcinoma - what’s the difference?

10.1186/s12903-023-03619-2 · ExternalCitation · doi-reference

Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study

10.1186/s12903-023-03760-y · ExternalCitation · doi-reference

Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review

10.1186/s12903-024-04179-9 · ExternalCitation · doi-reference

Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study

10.1186/s12903-024-04360-0 · ExternalCitation · doi-reference

Multifunctional photodynamic/photothermal nano-agents for the treatment of oral leukoplakia

10.1186/s12951-022-01310-2 · ExternalCitation · doi-reference

Adipose-derived stem cell exosomes attenuates myofibroblast transformation via inhibiting autophagy through TGF-β/Smad2 axis in oral submucosal fibrosis

10.1186/s12951-024-03067-2 · ExternalCitation · doi-reference

Elucidating the role of lipid metabolism dysregulation in the transition from oral lichen planus to oral squamous cell carcinoma

10.1186/s12967-025-06431-4 · ExternalCitation · doi-reference

The potential roles of cigarette smoke-induced extracellular vesicles in oral leukoplakia

10.1186/s40001-023-01217-0 · ExternalCitation · doi-reference

Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside

10.1631/jzus.b2200589 · ExternalCitation · doi-reference

Oral submucous fibrosis: an overview of a challenging entity

10.25259/ijdvl_371_20 · ExternalCitation · doi-reference

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21834 · ExternalCitation · doi-reference

Oral cancer and precancerous lesions

10.3322/canjclin.52.4.195 · ExternalCitation · doi-reference

Metabolic crosstalk between oral microbiota and the host in OSCC: emerging roles of microbial metabolites in tumor initiation and progression

10.3389/fcimb.2026.1778329 · ExternalCitation · doi-reference

Updates on immunological mechanistic insights and targeting of the oral Lichen planus microenvironment

10.3389/fimmu.2022.1023213 · ExternalCitation · doi-reference

Cell-free DNA promotes inflammation in patients with oral Lichen planus via the STING pathway

10.3389/fimmu.2022.838109 · ExternalCitation · doi-reference

Genetic changes driving immunosuppressive microenvironments in oral premalignancy

10.3389/fimmu.2022.840923 · ExternalCitation · doi-reference

Single-cell immune profiling reveals immune responses in oral Lichen planus

10.3389/fimmu.2023.1182732 · ExternalCitation · doi-reference

Single cell dissection reveals SFRP2+ fibroblasts amplifying inflammatory responses in oral lichen planus

10.3389/fimmu.2025.1553963 · ExternalCitation · doi-reference

Multiplex immunofluorescence assessment of macrophages and IL-23R in inflammatory and malignant diseases of the oral mucosa: a pilot study

10.3389/fimmu.2025.1569490 · ExternalCitation · doi-reference

Humoral immune activation within tertiary lymphoid structures is correlated with poor outcomes in oral Lichen planus and lichenoid lesions

10.3389/fimmu.2025.1667976 · ExternalCitation · doi-reference

Keratinocytes regulate intraepithelial lymphocytes homing and mediate mucosal barrier integrity via JAK2/STAT3 signaling in oral lichen planus

10.3389/fimmu.2026.1794867 · ExternalCitation · doi-reference

Hsa_circ_0060927 is a novel tumor biomarker by sponging miR-195-5p in the malignant transformation of OLK to OSCC

10.3389/fonc.2021.747086 · ExternalCitation · doi-reference

Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer

10.3389/fphar.2022.825266 · ExternalCitation · doi-reference

The antifibrotic and the anticarcinogenic activity of capsaicin in hot chili pepper in relation to oral submucous fibrosis

10.3389/fphar.2022.888280 · ExternalCitation · doi-reference

The mechanism of low molecular weight fucoidan-incorporated nanofiber scaffolds inhibiting oral leukoplakia via SR-A/Wnt signal axis

10.3389/fphar.2024.1397761 · ExternalCitation · doi-reference

A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia

10.3389/froh.2023.1088022 · ExternalCitation · doi-reference

A comprehensive analysis of the role of oxidative stress in the pathogenesis and chemoprevention of oral submucous fibrosis

10.3390/antiox11050868 · ExternalCitation · doi-reference

Salivary oxidative stress and antioxidant markers in oral leukoplakia: a systematic review and meta-analysis

10.3390/antiox15020218 · ExternalCitation · doi-reference

A systematic review of MicroRNA signatures associated with the progression of leukoplakia with and without epithelial dysplasia

10.3390/biom11121879 · ExternalCitation · doi-reference

Podoplanin expression independently and jointly with oral epithelial dysplasia grade acts as a potential biomarker of malignant transformation in oral leukoplakia

10.3390/biom12050606 · ExternalCitation · doi-reference

Are there betel quid mixtures less harmful than others? A scoping review of the association between different betel quid ingredients and the risk of oral submucous fibrosis

10.3390/biom12050664 · ExternalCitation · doi-reference

Molecular mechanisms in the carcinogenesis of oral squamous cell carcinoma: a literature review

10.3390/biom15050621 · ExternalCitation · doi-reference

Sensitive detection of oral leukoplakia: analyzing P90 biomarkers in saliva and tissue

10.3390/bios14060281 · ExternalCitation · doi-reference

A scoping review on gaps in the diagnostic criteria for proliferative verrucous leukoplakia: a conceptual proposal and diagnostic evidence-based criteria

10.3390/cancers13153669 · ExternalCitation · doi-reference

Oral proliferative verrucous leukoplakia: progression to malignancy and clinical implications. Systematic review and meta-analysis

10.3390/cancers13164085 · ExternalCitation · doi-reference

Exploring possible diagnostic precancerous biomarkers for oral submucous fibrosis: a narrative review

10.3390/cancers15194812 · ExternalCitation · doi-reference

A molecular hypothesis on malignant transformation of oral lichen planus: a systematic review and meta-analysis of cancer hallmarks expression in this oral potentially malignant disorder

10.3390/cancers16152614 · ExternalCitation · doi-reference

Implications of podoplanin overexpression in the malignant transformation of oral potentially malignant disorders: a systematic review and meta-analysis

10.3390/cancers17213448 · ExternalCitation · doi-reference

Risk assessment for malignant transformation in patients with oral proliferative leukoplakia: a 10-Year retrospective cohort study

10.3390/cancers18010002 · ExternalCitation · doi-reference

Diagnostic value of serum and salivary podoplanin as clinical biomarkers for distinguishing oral cancer from oral leukoplakia

10.3390/diagnostics16020206 · ExternalCitation · doi-reference

Microenvironment in oral potentially malignant disorders: multi-dimensional characteristics and mechanisms of carcinogenesis

10.3390/ijms23168940 · ExternalCitation · doi-reference

Hallmarks of cancer expression in oral lichen planus: a scoping review of systematic reviews and meta-analyses

10.3390/ijms232113099 · ExternalCitation · doi-reference

Oral submucous fibrosis: etiological mechanism, malignant transformation, therapeutic approaches and targets

10.3390/ijms24054992 · ExternalCitation · doi-reference

Macrophages CD163+ and factor XIIIa+ provide a first-line defence against proliferative verrucous Leukoplakia antigens

10.3390/ijms24065242 · ExternalCitation · doi-reference

Emerging role of decoy Receptor-2 as a cancer risk predictor in oral potentially malignant disorders

10.3390/ijms241814382 · ExternalCitation · doi-reference

Salivary biomarkers for oral cancer detection: an exploratory systematic review

10.3390/ijms25052634 · ExternalCitation · doi-reference

Chemopreventive potential of artemisinin and Rubus occidentalis in the progression of oral leukoplakia to oral cancer: a preclinical murine study

10.3390/ijms26178120 · ExternalCitation · doi-reference

The molecular interplay between oral microbiome and oral cancer pathogenesis

10.3390/ijms262010212 · ExternalCitation · doi-reference

Different approaches to oral Lichen planus treatment: a narrative review

10.3390/ijms27020914 · ExternalCitation · doi-reference

SOX2 expression is an independent predictor of oral cancer progression

10.3390/jcm8101744 · ExternalCitation · doi-reference

Long-term efficacy of 5-ALA photodynamic therapy in oral Lichen planus patients

10.3390/ph18111676 · ExternalCitation · doi-reference

HOXC-AS1 and EZH2 interaction increase HOXC9 expression and promote the malignant transformation of oral leukoplakia

10.7150/jca.103482 · ExternalCitation · doi-reference

Single-cell RNA sequencing highlights the immunosuppression of IDO1+ macrophages in the malignant transformation of oral leukoplakia

10.7150/thno.99112 · ExternalCitation · doi-reference